Laboratory Medicine ›› 2015, Vol. 30 ›› Issue (1): 53-57.DOI: 10.3969/j.issn.1673-8640.2015.01.013
Previous Articles Next Articles
ZHANG Guanghui1, CAO Xueping2, YU Jing2, LIU Ying2, GE Yan1
Received:2014-10-09
Online:2015-01-30
Published:2015-02-02
CLC Number:
ZHANG Guanghui, CAO Xueping, YU Jing, LIU Ying, GE Yan. Epidemiology and resistance mechanism study of carbapenem-resistant Acinetobacter baumannii[J]. Laboratory Medicine, 2015, 30(1): 53-57.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2015.01.013
| 引物 | 引物序列 | 预期长度 (bp) | 参考 文献 |
|---|---|---|---|
| OXA-23 | P1 5'-GATCGGATTGGAGAACCAGA-3' | 501 | [4] |
| P2 5'-ATTTCTGACCGCATTTCCAT-3' | |||
| OXA-24 | P1 5'-GGTTAGTTGGCCCCCTTAAA-3' | 246 | [4] |
| P2 5'-AGTTGAGCGAAAAGGGGATT-3' | |||
| OXA-51 | P1 5'-TAATGCTTTGATCGGCCTTG-3' | 353 | [4] |
| P2 5'-TGGATTGCACTTCATCTTGG-3' | |||
| OXA-58 | P1 5'-AAGTATTGGGGCTTGTGCTG-3' | 599 | [4] |
| P2 5'-CCCCTCTGCGCTCTACATAC-3' | |||
| IMP-1 | P1 5'-ACCGCAGCAGAGTCTTTGCC-3' | 587 | [5] |
| P2 5'-ACAACCAGTTTTGCCTTACC-3' | |||
| IMP-2 | P1 5'-GTTTTATGTGTATGCTTCC-3' | 678 | [5] |
| P2 5'-AGCCTGTTCCCATGTAC-3' | |||
| VIM-1 | P1 5'-AGTGGTGAGTATCCGACAG-3' | 261 | [5] |
| P2 5'-ATGAAAGTGCGTGGAGAC-3' | |||
| VIM-2 | P1 5'-ATGTTCAAACTTTTGAGTAAG-3' | 801 | [5] |
| P2 5'-CTACTCAACGACTGAGCG-3' | |||
| adeA | P1 5'- GGGTGTGATTCAAAAGAAGTCGC-3' | 169 | [6] |
| P2 5'-GAACCTTTTCAATGATACCTCCG-3' | |||
| adeB | P1 5'-AAAGACTTCAAAGAGCGGACTA-3' | 623 | [7] |
| P2 5'-TCACGCATTGCTTCACCC-3' | |||
| adeC | P1 5'-ACAATCGTATCTCGTGGACTC-3' | 361 | [6] |
| P2 5'-TAGAAACTGGGTTATTGGGGT-3' | |||
| adeJ | P1 5'-CCTATTGCACAATATCCAACGA-3' | 119 | [8] |
| P2 5'-AGGATAAGTCGCAGCAATCG-3' | |||
| adeG | P1 5'-GTCCTGAAATGGTCGTTCGT-3' | 143 | [8] |
| P2 5'-AGCTTCTGCTTGGCTAGATGA-3' | |||
| rpoB | P1 5'-TTCATCTAGCCAAGCAGAAG-3' | 200 | [9] |
| P2 5'-CCTGCTAATGGTAGGGTTAAG-3' |
| 引物 | 引物序列 | 预期长度 (bp) | 参考 文献 |
|---|---|---|---|
| OXA-23 | P1 5'-GATCGGATTGGAGAACCAGA-3' | 501 | [4] |
| P2 5'-ATTTCTGACCGCATTTCCAT-3' | |||
| OXA-24 | P1 5'-GGTTAGTTGGCCCCCTTAAA-3' | 246 | [4] |
| P2 5'-AGTTGAGCGAAAAGGGGATT-3' | |||
| OXA-51 | P1 5'-TAATGCTTTGATCGGCCTTG-3' | 353 | [4] |
| P2 5'-TGGATTGCACTTCATCTTGG-3' | |||
| OXA-58 | P1 5'-AAGTATTGGGGCTTGTGCTG-3' | 599 | [4] |
| P2 5'-CCCCTCTGCGCTCTACATAC-3' | |||
| IMP-1 | P1 5'-ACCGCAGCAGAGTCTTTGCC-3' | 587 | [5] |
| P2 5'-ACAACCAGTTTTGCCTTACC-3' | |||
| IMP-2 | P1 5'-GTTTTATGTGTATGCTTCC-3' | 678 | [5] |
| P2 5'-AGCCTGTTCCCATGTAC-3' | |||
| VIM-1 | P1 5'-AGTGGTGAGTATCCGACAG-3' | 261 | [5] |
| P2 5'-ATGAAAGTGCGTGGAGAC-3' | |||
| VIM-2 | P1 5'-ATGTTCAAACTTTTGAGTAAG-3' | 801 | [5] |
| P2 5'-CTACTCAACGACTGAGCG-3' | |||
| adeA | P1 5'- GGGTGTGATTCAAAAGAAGTCGC-3' | 169 | [6] |
| P2 5'-GAACCTTTTCAATGATACCTCCG-3' | |||
| adeB | P1 5'-AAAGACTTCAAAGAGCGGACTA-3' | 623 | [7] |
| P2 5'-TCACGCATTGCTTCACCC-3' | |||
| adeC | P1 5'-ACAATCGTATCTCGTGGACTC-3' | 361 | [6] |
| P2 5'-TAGAAACTGGGTTATTGGGGT-3' | |||
| adeJ | P1 5'-CCTATTGCACAATATCCAACGA-3' | 119 | [8] |
| P2 5'-AGGATAAGTCGCAGCAATCG-3' | |||
| adeG | P1 5'-GTCCTGAAATGGTCGTTCGT-3' | 143 | [8] |
| P2 5'-AGCTTCTGCTTGGCTAGATGA-3' | |||
| rpoB | P1 5'-TTCATCTAGCCAAGCAGAAG-3' | 200 | [9] |
| P2 5'-CCTGCTAATGGTAGGGTTAAG-3' |
| 按标本种类划分 | 按病区划分 | |||
|---|---|---|---|---|
| 来源 | 菌株数 | 病区 | 菌株数 | |
| 痰液 | 77 | ICU | 49 | |
| 胸、腹腔引流液 | 11 | 心胸外科病区 | 14 | |
| 全血(包括静脉穿刺) | 9 | 脑外科病区 | 13 | |
| 脑脊液 | 4 | 干部病区 | 10 | |
| 咽拭子 | 4 | 呼吸科病区 | 9 | |
| 创面分泌物 | 3 | 急诊病区 | 7 | |
| 气管插管 | 2 | 其它科室 | 8 | |
| 按标本种类划分 | 按病区划分 | |||
|---|---|---|---|---|
| 来源 | 菌株数 | 病区 | 菌株数 | |
| 痰液 | 77 | ICU | 49 | |
| 胸、腹腔引流液 | 11 | 心胸外科病区 | 14 | |
| 全血(包括静脉穿刺) | 9 | 脑外科病区 | 13 | |
| 脑脊液 | 4 | 干部病区 | 10 | |
| 咽拭子 | 4 | 呼吸科病区 | 9 | |
| 创面分泌物 | 3 | 急诊病区 | 7 | |
| 气管插管 | 2 | 其它科室 | 8 | |
| [1] | KANAFANI ZA, KARA L, HAYEK S, et al.Ventil-ator-associated pneumonia at a tertiary-care center in a developing country: incidence, microbiology, and susceptibility patterns of isolated microorganisms[J]. Infect Control Hosp Epidemiol, 2003, 24(11):864-869. |
| [2] | GOGOU V, POURNARAS S, GIANNOULI M, et al.Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09)[J]. J Antimicrob Chemother, 2011, 66(12):2767-2772. |
| [3] | LEMOS EV, DE LA HOZ FP, ALVIS N, et al. Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia[J]. Clin Microbiol Infect, 2014, 20(2):174-180. |
| [4] | VAHABOGLU H, BUDAK F, KACAP M, et al.High prevalence of OXA-51-type class D beta-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.:co-existence with OXA-58 in multiple centres[J]. J Antimicrob Chemother, 2006, 58(3):537-542. |
| [5] | SHIBATA N, DOI Y, YAMANE K, et al.PCR typing of genetic determinants for metallo-beta-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron[J]. J Clin Microbiol, 2003, 41(12):5407-5413. |
| [6] | HUANG L, SUN L, XU G, et al.Differential susceptibility to carbapenems due to the AdeABC efflux pump among nosocomial outbreak isolates of Acinetobacter baumannii in a Chinese hospital[J]. Diagn Microbiol Infect Dis, 2008, 62(3):326-332. |
| [7] | 侯盼飞, 祝丽晶, 宫凌娟, 等. 多重耐药鲍曼不动杆菌耐药性及AdeABC外排泵作用研究[J]. 中华临床医师杂志(电子版), 2012, 6(19) :6060-6062. |
| [8] | RUMBO C, GATO E, LÓPEZ M, et al. Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii[J]. Antimicrob Agents Chemother, 2013, 57(11):5247-5257. |
| [9] | YOON EJ, COURVALIN P, GRILLOT-COURVALIN C.RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations[J]. Antimicrob Agents Chemother, 2013, 57(7): 2989-2995. |
| [10] | DIJKSHOORN L, NEMEC A, SEIFERT H.An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii[J]. Nat Rev Microbiol, 2007, 5(12), 939-951. |
| [11] | ROCA I, ESPINAL P, VILA-FARRÉS X, et al. The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace[J]. Front Microbiol, 2012, 3:148. |
| [12] | CHAN MC, CHIU SK, HSUEH PR, et al.Risk factors for healthcare-associated extensively drug-resistant Acinetobacter baumannii infections: a case-control study[J]. PLoS One, 2014, 9(1):e85973. |
| [13] | LIN HC, LIN SM, KUO CH, et al.Incidence and outcome of healthcare-associated Acinetobacter baumannii in chronically ventilated patients in a tertiary care hospital in Taiwan[J]. Am J Med Sci, 2011, 341(5):361-366. |
| [14] | MAGNET S, COURVALIN P, LAMBERT T.Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454[J]. Antimicrob Agents Chemother, 2001, 45(12): 3375-3380. |
| [15] | DAMIER-PIOLLE L, MAGNET S, BRÉMONT S, et al. AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii[J]. Antimicrob Agents Chemother, 2008, 52(2): 557-562. |
| [16] | 彭俊华,张媛媛,付藏红,等. 鲍曼不动杆菌耐药表型及碳青霉烯酶OXA基因分析[J]. 现代检验医学杂志, 2009, 24(5):39-42. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||